These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Preclinical data released on PI. AIDS Patient Care STDS; 2003 Sep; 17(9):483-4. PubMed ID: 14596252 [No Abstract] [Full Text] [Related]
6. [HIV therapy of the next generation. Modern active drugs for long-term treatment]. MMW Fortschr Med; 2012 May; 154 Suppl 1():50-1. PubMed ID: 22916603 [No Abstract] [Full Text] [Related]
10. HIV postexposure prophylaxis after sexual assault: why is it so hard to accomplish? Cohen MS Sex Transm Dis; 2008 Dec; 35(12):979-80. PubMed ID: 18955917 [No Abstract] [Full Text] [Related]
11. Combination antiretroviral therapy with tenofovir, emtricitabine or lamivudine, and nevirapine. Redfield RR; Morrow JS Clin Infect Dis; 2008 Oct; 47(7):984-5. PubMed ID: 18778234 [No Abstract] [Full Text] [Related]
12. Predicting the antiviral activity of three-drug combinations in HAART. von Bubnoff A IAVI Rep; 2012; 16(2):22. PubMed ID: 22650058 [No Abstract] [Full Text] [Related]
13. Antiretroviral therapy: practice guidelines and National ART Programme. Bachani D; Rewari BB J Indian Med Assoc; 2009 May; 107(5):308, 310-4, 316 passim. PubMed ID: 19886386 [TBL] [Abstract][Full Text] [Related]
14. [Multidrug combination therapy in HIV infection treatment: "monotherapy has died, long live multidrug therapy!"]. Cabarcos Ortíz de Barrón A; Martínez Vázquez JM An Med Interna; 1998 Mar; 15(3):121-4. PubMed ID: 9567420 [No Abstract] [Full Text] [Related]
15. Initiating therapy: when to start, what to use. Hirsch MS J Infect Dis; 2008 May; 197 Suppl 3():S252-60. PubMed ID: 18447611 [TBL] [Abstract][Full Text] [Related]
17. Anti-HIV agents. The future of drug therapy. TreatmentUpdate; 2003; 15(5):1. PubMed ID: 17216854 [No Abstract] [Full Text] [Related]
18. Anti-HIV agents. Still searching for a cure. TreatmentUpdate; 2005; 17(6):1-2. PubMed ID: 17228473 [No Abstract] [Full Text] [Related]
19. Editorial comment: fixed-dose combination formulations are the answer, what was the question? Pavia AT AIDS Read; 2004 Oct; 14(10):549. PubMed ID: 15510391 [No Abstract] [Full Text] [Related]
20. Side effects and complications. Swedes compare treatment switching with interruption. TreatmentUpdate; 2005 Dec; 17(7):11. PubMed ID: 17225325 [No Abstract] [Full Text] [Related] [Next] [New Search]